Description
Three new Treasury Bills with maturities of 91, 182, and 364 days to be listed on BSE effective October 10, 2025.
Summary
BSE announces the listing of three new Treasury Bills (T-Bills) in the G GROUP - DEBT INSTRUMENTS category, effective October 10, 2025. The T-Bills have tenors of 91 days, 182 days, and 364 days with maturity dates ranging from January 2026 to October 2026.
Key Points
- Three new Treasury Bills to be listed on BSE effective October 10, 2025
- All securities listed in G GROUP - DEBT INSTRUMENTS
- Market lot of 1 for all three T-Bills
- 91-day T-Bill (Scrip: 805127, ISIN: IN002025X281) maturing January 8, 2026
- 182-day T-Bill (Scrip: 805128, ISIN: IN002025Y289) maturing April 9, 2026
- 364-day T-Bill (Scrip: 805129, ISIN: IN002025Z286) maturing October 8, 2026
- Trading will be suspended two working days prior to maturity/redemption date
Regulatory Changes
No regulatory changes. This is a standard listing notification for new government securities.
Compliance Requirements
- Trading members must note the securities will not be available for trading two working days before maturity/redemption date (T-2 trading days, excluding bank holidays)
- Trading members should contact BSE at 2272 8352/5753/8597 for any clarifications
Important Dates
- Listing Date: October 10, 2025
- 91-day T-Bill Maturity: January 8, 2026 (Symbol: 91TB080126)
- 182-day T-Bill Maturity: April 9, 2026 (Symbol: 182TB90426)
- 364-day T-Bill Maturity: October 8, 2026 (Symbol: 364TB81026)
- Trading Suspension: Two working days before respective maturity dates
Impact Assessment
Minimal market impact. This is a routine administrative notification for the listing of government treasury bills. The addition of these short-term government securities provides trading members with additional debt instruments for portfolio management and liquidity operations. No significant operational changes required for market participants.
Impact Justification
Routine listing of government treasury bills with standard market lots and trading procedures. No significant market impact or compliance burden.